Clinical management of amyloid cardiomyopathy

Morris M. Kim, Clinton M. Kolseth, Dayna Carlson, Ahmad Masri

Research output: Contribution to journalReview articlepeer-review

Abstract

Clinical heart failure, restrictive cardiomyopathy, and arrhythmias are hallmark features of amyloid cardiomyopathy. In contrast to the advancements in targeted therapies, there is a general lack of evidence-based practice guidelines for clinical management of amyloid cardiomyopathy. In this review, we review the role of routine medical therapy in amyloid cardiomyopathy, from heart failure management to orthostatic hypotension, atrial arrhythmias, thromboembolic complications, and prevention of sudden death. We conclude by discussing approaches to patients with end-stage disease.

Original languageEnglish (US)
JournalHeart Failure Reviews
DOIs
StateAccepted/In press - 2021
Externally publishedYes

Keywords

  • Amyloidosis
  • Atrial fibrillation
  • Heart failure
  • Orthostatic hypotension
  • Restrictive cardiomyopathy
  • Sudden cardiac death

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Clinical management of amyloid cardiomyopathy'. Together they form a unique fingerprint.

Cite this